Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
Copyright policy )Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
Sphingosine kinase 1 (SphK1) is a promising therapeutic target against several diseases including mammary cancer. The aim of present work is to identify a potent lead compound against breast cancer using ligand-based virtual screening, molecular docking, MD simulations, and the MMPBSA calculations. The LBVS in molecular and virtual libraries yielded 20,800 hits, which were reduced to 621 by several parameters of drug-likeness, lead-likeness, and PAINS. Furthermore, 55 compounds were selected by ADMET descriptors carried forward for molecular interaction studies with SphK1. The binding energy (ΔG) of three screened compounds namely ZINC06823429 (-11.36 kcal/mol), ZINC95421501 (-11.29 kcal/mol), and ZINC95421070 (-11.26 kcal/mol) exhibited stronger than standard drug PF-543 (-9.9 kcal/mol). Finally, it was observed that the ZINC06823429 binds tightly to catalytic site of SphK1 and remain stable during MD simulations. This study provides a significant understanding of SphK1 inhibitors that can be used in the development of potential therapeutics against breast cancer.
- University of Electronic Science and Technology of China China (People's Republic of)
- Islamic University Bangladesh
- Imam Muhammad ibn Saud Islamic University Saudi Arabia
- Integral University India
Models, Molecular, md simulation, Dose-Response Relationship, Drug, Molecular Structure, Drug Evaluation, Preclinical, Antineoplastic Agents, Breast Neoplasms, molecular docking, RM1-950, Phosphotransferases (Alcohol Group Acceptor), Structure-Activity Relationship, breast cancer, Humans, Therapeutics. Pharmacology, Drug Screening Assays, Antitumor, Enzyme Inhibitors, mmpbsa calculations, sphk1, Research Paper, Cell Proliferation
Models, Molecular, md simulation, Dose-Response Relationship, Drug, Molecular Structure, Drug Evaluation, Preclinical, Antineoplastic Agents, Breast Neoplasms, molecular docking, RM1-950, Phosphotransferases (Alcohol Group Acceptor), Structure-Activity Relationship, breast cancer, Humans, Therapeutics. Pharmacology, Drug Screening Assays, Antitumor, Enzyme Inhibitors, mmpbsa calculations, sphk1, Research Paper, Cell Proliferation
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).46 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!